Solstein Capital’s Elevance Health ELV Stock Holding History

Solstein Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-130	Closed	-$59K	–	299
2022 Q3	$59K	Hold	130	–	–	0.05%	146
2022 Q2	$63K	Hold	130	–	–	0.05%	166
2022 Q1	$64K	Hold	130	–	–	0.04%	175
2021 Q4	$60K	Hold	130	–	–	0.04%	198
2021 Q3	$48K	Hold	130	–	–	0.03%	235
2021 Q2	$50K	Hold	130	–	–	0.06%	216
2021 Q1	$47K	Buy	+130	New	+$41.8K	0.06%	202
2020 Q4	–	Sell	-130	Closed	-$35K	–	126
2020 Q3	$35K	Hold	130	–	–	0.08%	148
2020 Q2	$34K	Hold	130	–	–	0.08%	136
2020 Q1	$30K	Sell	130 -677	-84%	-$184K	0.12%	103
2019 Q4	$244K	Buy	+807	New	+$222K	0.49%	47

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Solstein Capital's ELV Position: Q4 2022 in Review

Solstein Capital sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 130 shares — an estimated $59K sold.

Solstein Capital first reported a position in ELV in Q4 2019 and held it in 11 quarters. The position peaked at $244K in Q4 2019. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

Solstein Capital reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
Solstein Capital sold 130 Elevance Health shares in Q4 2022, an estimated $59K.
Solstein Capital first reported a position in Elevance Health in Q4 2019 and held it in 11 quarters.
Solstein Capital's Elevance Health position peaked at $244K in Q4 2019.
1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Solstein Capital's 13F filing for Q4 2022, filed 2 Feb 2023.